{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:09:47Z","timestamp":1789524587311,"version":"build-2803163510"},"reference-count":37,"publisher":"Informa UK Limited","issue":"5","funder":[{"name":"Vietnam Ministry of Health","award":["4694\/QD-BYT"],"award-info":[{"award-number":["4694\/QD-BYT"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharmacogenomics"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.2217\/pgs-2021-0156","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T12:42:05Z","timestamp":1645447325000},"page":"303-313","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":16,"title":["Allopurinol-Induced Severe Cutaneous Adverse Reactions in Vietnamese: The Role of\n            <i>HLA<\/i>\n            Alleles and Other Risk Factors"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4972-614X","authenticated-orcid":false,"given":"Tran Thu","family":"Ha Pham","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Hanoi University of Pharmacy, Hanoi, 10000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3520-2131","authenticated-orcid":false,"given":"Quang Binh","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Nutrition &amp; Non-communicable Diseases, National Institute of Nutrition, Hanoi, 10000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9917-3064","authenticated-orcid":false,"given":"Chi Hieu","family":"Chu","sequence":"additional","affiliation":[{"name":"Center of Allergology &amp; Clinical Immunology, Bach Mai Hospital, Hanoi, 10000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0126-314X","authenticated-orcid":false,"given":"Thi Quynh","family":"Nga Do","sequence":"additional","affiliation":[{"name":"Department of Immunology &amp; Molecular Biology, National Institute of Hygiene &amp; Epidemiology, Hanoi, 10000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9643-1678","authenticated-orcid":false,"given":"Hoang Anh","family":"Nguyen","sequence":"additional","affiliation":[{"name":"The National Centre of Drug Information &amp; Adverse Drug Reaction Monitoring, Hanoi University of Pharmacy, Hanoi, 10000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5675-0850","authenticated-orcid":false,"given":"Dinh Van","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of\u00a0Internal Medicine, Respiratory, Allergy &amp; Clinical Immunology Unit, Vinmec Healthcare system, Hanoi, 10000, Vietnam"},{"name":"College of Health Sciences, VinUniversity, Hanoi, 10000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7669-5983","authenticated-orcid":false,"given":"Thanh Huong","family":"Phung","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Hanoi University of Pharmacy, Hanoi, 10000, Vietnam"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"e_1_3_4_2_1","first-page":"4320195","article-title":"The epidemiology of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in China","volume":"2018","author":"Yang SC","year":"2018","unstructured":"Yang SC , HuS , ZhangSZet al. The epidemiology of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in China. J. Immunol. Res.2018, 4320195 (2018).","journal-title":"J. Immunol. Res."},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2020.101501"},{"key":"e_1_3_4_4_1","doi-asserted-by":"crossref","unstructured":"Cho YT YangCW ChuCY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs viruses and immune system. 18(6) 1243 (2017).","DOI":"10.3390\/ijms18061243"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13430"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12754"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/FPC.0b013e32834282b8"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.132"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0409500102"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2867"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02273-1"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2019-0146"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.12932\/AP-201120-1000"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/TACG.S278652"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252"},{"key":"e_1_3_4_16_1","doi-asserted-by":"crossref","unstructured":"Naranjo CA BustoU SellersEMet al. A method for estimating the probability of adverse drug reactions. 30(2) 239\u2013245 (1981).","DOI":"10.1038\/clpt.1981.154"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12388434"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2017.9.1.79"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","unstructured":"Benjamini Y HochbergY. Controlling the false discovery rate: a practical and powerful approach to multiple testing. 57(1) 289\u2013300 (1995).","DOI":"10.1111\/j.2517-6161.1995.tb02031.x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1955.tb01285.x"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","unstructured":"Dormann CF ElithJ BacherSet al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. 36(1) 27\u201346 (2013).","DOI":"10.1111\/j.1600-0587.2012.07348.x"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-017-0584-6"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4848"},{"key":"e_1_3_4_25_1","first-page":"1","article-title":"Clinical Usefulness of HLA-B\u221758:01 genotyping in gouty arthritis","volume":"19","author":"Yu C","year":"2019","unstructured":"Yu C , MokC. Clinical Usefulness of HLA-B\u221758:01 genotyping in gouty arthritis. J. Clin. Rheumatol.19, 1\u20137 (2019).","journal-title":"J. Clin. Rheumatol."},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13143"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-167"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0213-9111(08)75363-9"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12389"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.00383"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00982.x"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-013-0084-0"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13250"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205577"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.02.808"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12184"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex253"},{"key":"e_1_3_4_38_1","doi-asserted-by":"crossref","unstructured":"Manson LEN SwenJJ GuchelaarHJ. Diagnostic test criteria for HLA genotyping to prevent drug hypersensitivity reactions: a systematic review of actionable HLA recommendations in CPIC and DPWG guidelines. Front Pharmacol.11(1450) 1\u20138 (2020).","DOI":"10.3389\/fphar.2020.567048"}],"container-title":["Pharmacogenomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/pgs-2021-0156","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T11:40:10Z","timestamp":1715946010000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/pgs-2021-0156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10.2217\/pgs-2021-0156"],"URL":"https:\/\/doi.org\/10.2217\/pgs-2021-0156","relation":{},"ISSN":["1462-2416","1744-8042"],"issn-type":[{"value":"1462-2416","type":"print"},{"value":"1744-8042","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ipgs20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}